Labetalol Hydrochloride Injection, USP, 100 mg/20 mL (5 mg/mL), 20 mL Multidose Vial, packaged 50/20 mL glass vials/carton, Hospira, Inc., Lake Forest, IL 60045 --- NDC 0409-2267-20
Published July 16, 2014 · Recall initiated: May 16, 2014
Summary
FDA records drug Class II recall D-1424-2014, published July 16, 2014 and initiated May 16, 2014. Recalling firm: Hospira Inc.; Status: Terminated; Reported quantity: 45,448 vials; Lot: Lot 36225DD, exp 12/01/2015. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of Particulate Matter; metal embedded in the glass vial and visible particles floating in the solution
What to do
Voluntary: Firm initiated · Press Release
Get an email if LABETALOL HYDROCHLORIDE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- LABETALOL HYDROCHLORIDE
- Manufacturer
- Hospira Inc.
- Distributor
- Nationwide
- Lot
- Lot 36225DD, exp 12/01/2015
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDALabetalol Hydrochloride Injection, USP, 20 mg/4 mL (5 mg/mL), 4 mL Single-dose Carpuject, Sterile CartridgeJuly 3, 2024
- FDALabetalol Hydrochloride Injection, USP, 100 mg/ 20 mL (5 mg/mL), 20 mL Multidose Vial, Rx only, labeled as a)March 14, 2018
- FDATyvaso (treprostinil) Inhalation Solution, Treprostinil 1.74 mg/2.9 mL, Four 2.9 mL Ampules, For OralJuly 16, 2014
- FDAHeparin Sodium in 5% Dextrose Injection, Heparin, 25,000 USP Heparin Units/250 mL (100 USP Heparin Units/mL),July 16, 2014
- FDABUPivacaine HCl 0.25% Preservative Free (2.5 mg/mL) 500 mL in On-Q C-bloc (2-14 mL/hr) bag, Healix InfusionJuly 16, 2014
- FDAENDOMETRIN (progesterone) Vaginal Insert 100 mg USP, 21 inserts, Rx Only, Manufactured for: FerringJuly 16, 2014
Questions about this recall
Was Labetalol Hydrochloride Injection, USP, 100 mg/20 mL (5 mg/mL), 20 mL Multidose Vial, packaged 50/20 mL glass vials/carton, Hospira, Inc., Lake Forest, IL 60045 --- NDC 0409-2267-20 recalled?
Yes. FDA published recall D-1424-2014 on July 16, 2014. Reported hazard: Presence of Particulate Matter; metal embedded in the glass vial and visible particles floating in the solution
What should I do if I have this product?
Voluntary: Firm initiated · Press Release
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: LABETALOL HYDROCHLORIDE.